RT Journal Article SR Electronic T1 Distinct impact of IgG subclass and Fc-FcγR interaction on autoantibody pathogenicity in different IgG4-mediated diseases JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.12.07.20243774 DO 10.1101/2020.12.07.20243774 A1 Yanxia Bi A1 Jian Su A1 Shengru Zhou A1 Yingjie Zhao A1 Yan Zhang A1 Huihui Zhang A1 Mingdong Liu A1 Aiwu Zhou A1 Meng Pan A1 Yiming Zhao A1 Fubin Li YR 2020 UL http://medrxiv.org/content/early/2020/12/08/2020.12.07.20243774.abstract AB IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function and is considered anti-inflammatory in the context of prolonged inflammation and allergic responses. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity.Competing Interest StatementA patent application based on the study is being prepared for submission, and Fubin Li, Yanxia Bi, Yan Zhang, and Huihui Zhang are listed as inventors.Clinical TrialData included in this paper come from a retrospective study.Funding StatementThis work was supported by NNSFC projects No. 31422020 and 31870924. Y.M.Z. is supported by NNSFC project No. 81873431 and Jiangsu Provincial Natural Science Foundation No. BK20181164. Y.Z. is supported by Shanghai Sailing Program No. 16YF1409700. H.Z. is supported by Shanghai Municipal Natural Science Foundation project No. 15ZR1436400 and Shanghai Young Oriental scholar program 2015 by Shanghai Municipal Education Commission. F.L., Y.Z., and H.Z. are also supported by the innovative research team of high-level local universities in Shanghai (SSMU-2DCX20180100).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from the Ethics Committees in The Rui Jin Hospital of Shanghai Jiao Tong University School of Medicine and The First Affiliated Hospital of Soochow University, respectively. All PF and TTP patients and healthy volunteers signed informed consent. All mice were bred and maintained under specific pathogen-free (SPF) conditions, and all animal experiments were performed under the institutional guidelines of the Shanghai Jiao Tong University School of Medicine Institutional Animal Care and Use Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and materials generated or analyzed during this study are either included in this manuscript (Figures and supplementary information) or available upon reasonable request.